Access to cannabis for medical and scientific purposes RIS

Access to cannabis for medicinal purposes through the first pathway, such as occurred for Sativex, requires a robust dossier of clinical trial and other data and is commonly submitted after some years of significant commercial investment. ................
................

In order to avoid copyright disputes, this page is only a partial summary.